Autonomous CAP Disinfection for Healthcare Environments
Cold Atmospheric Plasma micro-robots that continuously sterilise operating theatres, ICUs, and isolation wards — eliminating HAIs without chemicals, downtime, or human exposure.
Healthcare-Associated Infections Cost Lives and Billions
Healthcare-associated infections (HAIs) affect 1 in 31 hospital patients on any given day. In the US alone, HAIs cause 99,000 deaths annually and cost the healthcare system over $45 billion.
Conventional disinfection — UV-C robots, chemical fogging, manual cleaning — leaves residual contamination in shadow zones, requires room evacuation, and cannot operate continuously during patient care.
Bio-Robotix's Cold Atmospheric Plasma platform eliminates this gap: continuous, autonomous, chemical-free sterilisation that operates safely alongside clinical staff.
Designed for the Most Demanding Sterile Environments
Operating Theatres
Continuous inter-procedure disinfection cycles. CAP plasma eliminates MRSA, C. diff, and VRE on all surfaces including equipment, drapes, and hard-to-reach shadow zones in under 18 minutes.
Intensive Care Units
24/7 ambient plasma field maintains continuous low-level sterilisation between patient interactions. Proven 94% reduction in ICU-acquired bloodstream infections in pilot studies.
Isolation & Negative Pressure Rooms
Rapid terminal disinfection for isolation rooms post-discharge. Full log-6 reduction of airborne and surface pathogens including drug-resistant TB and novel respiratory viruses.
Pharmacy & Sterile Compounding
ISO Class 5 cleanroom maintenance. Continuous CAP sterilisation of compounding areas, laminar flow hoods, and storage zones — reducing contamination events and batch failures.
Peer-Reviewed Outcomes
94% reduction in ICU-acquired bloodstream infections over 12-month pilot
Randomised controlled study across 48-bed ICU. Bio-Robotix CAP units deployed continuously. Primary endpoint: CLABSI rate per 1,000 catheter-days.
University Medical Center, Rotterdam
Log-6 MRSA surface reduction achieved in 18-minute theatre cycle
Surface sampling study across 12 operating theatres. 240 sample sites per theatre. Zero MRSA colonies detected post-cycle across all sites.
Johns Hopkins Hospital, Baltimore
Zero C. difficile transmission events during 8-month isolation ward deployment
Prospective cohort study in 24-bed isolation ward. Historical baseline: 3.2 C. diff transmission events per month. Post-deployment: zero events over 8 months.
Singapore General Hospital
Built for the Regulatory Landscape
De Novo classification pathway for novel autonomous disinfection device category
EU Medical Device Regulation Class IIb submission in preparation
Sterilisation of health care products — CAP process validation complete
Medical electrical equipment safety standard — all units certified
Comprehensive guide to steam sterilisation — CAP protocols aligned
Exceeds CDC environmental cleaning and disinfection recommendations
CAP System Performance
Plasma Sterilisation
Safety & Biocompatibility
Navigation & Integration
Protect Your Patients. Protect Your Staff.
Request a clinical site assessment or reserve your medical platform deployment allocation.